FOXO Technologies Expands Myrtle Recovery Centers Services

An announcement from FOXO Technologies ( (FOXO) ) is now available.

On May 6, 2025, FOXO Technologies announced that its subsidiary, Myrtle Recovery Centers, Inc., has achieved significant patient care milestones since starting operations in August 2023. Myrtle has treated over 400 patients and provided more than 5,000 care days at its Tennessee facility. The company plans to expand its services due to increasing demand, which is expected to enhance its presence and revenue contribution to FOXO Technologies.

Spark’s Take on FOXO Stock

According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.

FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.

To see Spark’s full report on FOXO stock, click here.

More about FOXO Technologies

FOXO Technologies Inc. operates in the biotechnology and healthcare industry, owning three subsidiaries: Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and FOXO Labs, Inc. Rennova operates a critical access hospital in East Tennessee, Myrtle provides inpatient and outpatient behavioral health services, and FOXO Labs focuses on biotechnology solutions to improve human health and lifespan.

Average Trading Volume: 738,065

Technical Sentiment Signal: Sell

Current Market Cap: $2.8M

For detailed information about FOXO stock, go to TipRanks’ Stock Analysis page.